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Multi-period theoretical models of renewable insurance display front-loaded premium schedules that
both cover lifetime total claims of low-risk and high-risk individuals and provide an incentive for
those who remain low-risk to continue to purchase the policy. In practice, however, an age profile
of premiums that decreases with age might result in relatively high premiums for younger
individuals which they may consider unaffordable. In this paper, we use medical expenditure data
to estimate an optimal competitive age-based premium schedule for a benchmark renewable health
insurance policy. We find that the amount of prepayment by younger individuals that would be
necessary to cover future claims is mitigated by three factors: high-risk individuals will either
recover or die, low-risk expected expense increases with age, and the likelihood of developing a
high-risk condition increases with age. Although medical cost growth over time increases the
amount of prepayment necessary, the resulting optimal premium path generally increases with age.
We also find that actual premium paths exhibited by purchasers of individual insurance with
guaranteed renewability is close to the optimal schedule we estimate. Finally, we examine
consumers' gain in expected utility associated with the guaranteed renewability feature.
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I.  INTRODUCTION 
I.A.  Background 
  Not all illness-related events begin and end within the single-year time frame that is 
typical for private health insurance policies.  This means that a person initially in good health 
who develops a chronic illness may have above-average expenses in subsequent years.  If the 
annual insurance premium is set proportional to expected expense in each year, the person who 
contracts a multi-year condition would face a substantial and unexpected jump in premiums, 
something a risk-averse person would prefer to avoid.  A potential solution to this problem is for 
the insurance policy purchased when the individual is still in good health to contain a guaranteed 
renewability (GR) provision which stipulates that no insured￿s future premium for the given 
policy will increase more than any other insured￿s premium increases.  That is, people who 
become high-risk will pay the same premium as those who remain low-risk.   
  However, in a world of competitive unsubsidized insurance firms, the insurer faces a 
dilemma.  If some individuals who are low-risk in period one will become high-risk in period 
two, any resulting second-period premium based only on these higher expected expenses may 
drive away from the plan those who remain low-risk.  They will be attracted to other firms 
promising to charge them no more than their own expected expenses.  In this sense, the promise 
to ￿community rate￿ insurance in the future for the population of initial purchasers is not 
sustainable in competitive insurance markets.   
  There is, however, a solution in theory to this problem, as suggested by Cochrane [1995] 
and Pauly, Kunreuther, and Hirth [1995].  The premium the insurer should charge the low-risk 
individuals in period one should be higher than the expected expense for that population in 
period one.  The ￿extra￿ premium is used to cover the subsequent above-average expenses of  2
those who became high-risk between period one and period two.  It would then be possible to 
charge a premium equal to the low-risk individuals￿ expected expense in period two; at this 
premium, both those who became high-risk and those who remain low-risk would remain with 
the insurer.  Moreover, risk-averse individuals will prefer paying the somewhat higher premium 
in period one to paying a lower premium in period one and facing the uncertainty of above-
average premiums in period two.  The expected lifetime premiums are the same under both 
scenarios, but ￿front-loading￿ the first-period premium produces an ￿incentive-compatible￿ 
schedule of premiums which risk-averse individuals prefer to facing single-period risk-rated 
insurance.   
  In just a two-period model, the additional premium in period one need not be large.  
However, selling insurance to young people that will guarantee premiums in the face of a chronic 
illness that persists for many years into the future might require charging a substantial extra 
premium to cover the future expected excess expense for those who become high risk.  Figure 1 
illustrates what the theoretically-implied GR premium schedule would look like for a initially 
low-risk population in which individuals face a constant per-period probability of becoming (and 
remaining) high risk.  Whereas a simple premium schedule based on age would obviously 
increase with age, the incentive-compatible guaranteed renewable premium schedule under this 
set of simple assumptions would decrease with age.  Even with an insurer￿s ability to earn a rate 
of return on any reserves set aside for future claims, the additional premium to cover 40 or more 
years of above-average spending might be quite high.  If people could borrow in a perfect capital 
market to pay this premium, they would do so.  But, as Frick [1999] points out, with imperfect 
capital markets, young people￿particularly those with lower incomes￿might be unable to  3
borrow on reasonable terms and therefore be unable to afford (even if behaving rationally in all 
other ways) high initial premiums.  
  However, this pattern of excessively high initial premiums may not be realistic for health 
insurance.  The simple model assumed that the expected expenses for low-risk individuals stayed 
constant over time, that a given proportion of the low-risk population converted to high risk in 
every period, and that individuals remain high-risk for all remaining periods.  These assumptions 
may well not hold for health insurance.  Expected expenses even for healthy or normal people 
almost surely increase with age.  Similarly, the probability of contracting a chronic condition 
also almost surely increases with age.  And finally, the time period over which people remain 
high-risk, on average, is less than the average lifetime.  (These conjectures are confirmed below 
with our medical expenditure data.)   
  The implication of these modifications is that, in principle, the premium needed to fund 
GR coverage might actually be moderate at a young age compared to what it will become later.  
In fact, premiums for guaranteed renewable coverage for people in their twenties (including 
enough to cover the excess expense of those who will become chronic high risks) could well be 
lower than the premiums for healthy people in their sixties, since the latter￿s expected expenses 
would be higher and more of them would be becoming high risks (if only until they go on 
Medicare).  Applying a positive interest rate to the excess reserves collected by insurers would 
also smooth the life-long pattern of premiums.   
  At a theoretical level, this observation does not, in itself, necessarily provide a solution to 
Frick￿s problem of imperfect capital markets.  Markets may be imperfect in many ways, and 
even with premiums that are relatively low for the young, those people may so prefer current 
consumption that they sacrifice GR protection.  The real issue is empirical:  what schedule of  4
lifetime premiums related to age would individuals prefer?  This paper does not answer that 
question directly.  But it does estimate a feasible breakeven incentive-compatible premium 
schedule and approximates the willingness-to-pay for that schedule of lifetime premiums.  We 
also relate these schedules to typical lifetime income patterns; in an informal way this 
comparison may suggest how ￿affordable￿ an incentive-compatible schedule would be.   
  There is another empirical fact that is relevant.  GR health insurance policies (as well as 
GR term life and nursing home insurance) do exist in (and dominate) the market, even in the 
absence of regulation, and appear to be stable [Pauly, Percy, and Herring, 1999; Harrington and 
Niehaus, 1999].  We want to see whether that apparent stability is consistent with an incentive-
compatible premium schedule.  In a sense, we are elaborating on the old joke:  ￿Sure, it works in 
practice, but could it work in theory?￿ because developing the theory that fits with practice may 
further illuminate both. 
Our approach follows and extends the work of Hendel and Lizzeri [2003] for term life 
insurance.  They do not deal with guaranteed renewability per se (despite its very common 
presence in term life insurance markets [Harrington and Niehaus, 1999]), but instead use the 
more explicit insurer commitment to future premiums present in policies with different lengths 
of term.  We show that essentially the same results can be obtained with guaranteed renewability 
and single-year policies, and we go beyond Hendel and Lizzeri in providing direct comparisons 
of the extent of ￿front-loading￿ of actual premiums paid with an estimate of the optimal age-path 
of premiums.   
  The existence of GR features can also help to explain a seeming paradox in the 
relationship between nongroup insurance premiums actually paid and risk.  The nongroup 
insurance market is thought to tailor premiums to risk, but in our previous research, we  5
discovered that, although insurance premiums increase with age, the increase is much less than 
proportional to the increase in expected expenses with age [Pauly and Herring, 1999; Herring 
and Pauly, 2001].  Expected expenses approximately quadruple between the ages of 25 and 60, 
but paid premiums (for the same level of coverage) increase only about two-and-a-half times.  
Moreover, we could not detect a statistically significant relationship between one￿s risk level, 
given one￿s age, and the premiums paid.  But such a dampening of the age-related pattern of 
premiums is exactly what would be predicted if GR were in effect and insurers were pricing 
rationally.
1  And if renewability were guaranteed at average premiums regardless of risk, 
premiums would be unrelated to risk for those who renew.  One implication of this is that what 
an insurer would charge a 50-year-old applying for new insurance will generally be more than 
what the average 50-year-old, protected by GR, pays for ￿old￿ renewed insurance.   
  
I.B.  Overview   
  In this paper, we explicitly estimate the age profile of a GR premium schedule predicted 
by the theory outlined above, using the individual-level data in the Medical Expenditure Panel 
Survey (MEPS).  We estimate expected medical expenses based on age, gender, and health 
status.  We then consider a benchmark insurance policy, and we ￿piece together￿ the ideal GR 
premium schedule for that policy which will cover lifetime expected claims for both low-risk and 
high-risk individuals yet will provide an incentive for the low-risk individuals to remain with the 
policy.  We also compare this GR premium schedule we estimate to actual nongroup insurance 
premiums from the Community Tracking Study￿s Household Survey.  We then examine 
consumers￿ willingness-to-pay for this GR feature by producing estimates of both the benefits 
from avoiding the uncertainty of future-period risk-rated premiums and the ￿capital constraint￿  6
cost associated with the prepayment of GR premiums.  Finally, we make some general 
observations about the feasibility of GR health insurance based upon our findings.   
  Since incentive-compatible guaranteed renewable premium schedules require an insurer 
to collect prepayments in order to cover the future claims of high-risk individuals (in excess of 
the claims of low-risk individuals), our model needs to account for projected growth rates in 
medical costs over time.  Even though the premium can be increased to keep up with ￿pure￿ 
medical spending growth for the lower risks who are retained in the pool, the prepayments also 
need to cover anticipated spending growth for the higher risks above that for the lower risks.  We 
do not, however, consider the case in which there are ex post realizations of cost growth which 
differ from the ex ante forecasts made, thereby creating unpredictable losses or gains to the 
insurer.
2  We do however comment on the magnitude of this non-diversifiable risk and make a 
suggestion for potential diversification.  One other aspect of long-term contracting in health 
insurance which we do not consider in this paper is the enforceability of such long-term 
contracts; there exists the potential for unscrupulous insurers to engage in either ￿re-
underwriting￿ high-risk individuals or canceling a block of business in order to screen out high-
risk individuals from new policies.
3  We assume below that, because of effective regulation, 
reputation effects, or the threat of legal action, insurers do not violate their insurance contracts.   
 
II.  METHODS AND MAIN RESULTS 
II.A.  Estimating Expected Expense   
  We use data from the 1996, 1997, 1998, and 1999 Medical Expenditure Panel Surveys 
(MEPS) to produce individual-level estimates of expected expense for individuals of various 
ages and health risk levels.  The MEPS is a nationally-representative household survey  7
containing detailed information on demographic characteristics, health conditions, insurance 
status, and medical expenses.  We first identify a pooled sample of 33,884 privately-insured 
individuals ages 18 to 64 from the four survey years, and we inflate each year￿s expenditure data 
to 2003 dollars using the annual growth rates for both private out-of-pocket payments and private 
health insurance payments identified by the National Health Expenditures data from the Centers 
for Medicare and Medicaid Services; these growth rates are presented in Heffler et al. [2003].  
Since individuals in the MEPS held various types of plans with different cost-sharing provisions, 
we apply the American Academy of Actuaries [1995] induction methodology to standardized 
each individual￿s expenditures (i.e., total expenses, benefits, and out-of-pocket payments) to a 
benchmark plan, assumed to have a $200 deductible, 25 percent coinsurance, and a $2500 out-
of-pocket maximum.     
  We then use these data on actual insurance benefit payments to estimate individual-level 
expected benefits using a two-part regression model.
4  The first part is a logistic regression 
model predicting the probability of having any nonzero benefits, and the second is an OLS model 
predicting (untransformed linear) benefits for the sample of those with nonzero benefits.
5  The 
individual characteristics include binary variables for five-year age intervals interacted with 
gender and binary variables identifying the absence of any prior chronic conditions or the 
presence of the following twelve different medical conditions: cancer, diabetes, emphysema, 
high cholesterol, hypertension, heart disease, stroke, arthritis, asthma, gall bladder disease, 
stomach ulcer, and back problems.  The MEPS identifies the year each of these conditions was 
discovered, and since we are interested in obtaining forecasts of expected expense using pre-
existing conditions, we include indicators for only those conditions that were discovered prior to 
the survey year.
6  Because high risks on average either die relatively soon after their conditions  8
are discovered or recover from their illnesses, the median period of unusually high expenses is 
only about four years [Eichner, McClellan, and Wise, 1998].  (Obviously some people who 
become high risks do remain that way for a longer period of time.)  For this reason, we identify 
each of the twelve conditions in our regression model by whether it was discovered less than five 
years ago or more than five years ago.   
  The results from this regression analysis are presented in Table 1.  The second column of 
this table shows mean statistics for the privately-insured MEPS sample, the third column shows 
results for the logistic regression model predicting any insurance benefits, the fourth column 
shows OLS results for untransformed ￿conditional￿ insurance benefits, and the final column 
shows a ￿simulated￿ marginal effect from combining the logistic and OLS estimates.  (We 
determine this combined marginal effect for each variable by producing individual-level 
estimates of expected expense for the entire sample both ￿turning on and off￿ the relevant 
variable; the marginal effect for that variable is then the difference in mean expected expenses 
for the two samples.)  The coefficients on age suggest that, even after controlling for higher 
expenses related to the presence of a high-expense condition, expected expense increases with 
age (aside from the slight decrease in expense for women after child-bearing age).  Moreover, 
the results also demonstrate the dampening of the magnitude of condition-related expenses over 
time for many of the conditions.  That is, a more-recent condition￿s marginal effect on expected 
expense is often higher than a less-recent condition￿s marginal effect on expected expense; these 
patterns of a diminishing effect for most conditions with time are much less dramatic than what 
would be observed if we included the conditions discovered during the survey year.  However, 
for a few conditions, particularly stroke and gall bladder disease, the pattern of condition-related 
expense over time is the reverse.    9
 
II.B.  Hypothetical Age-Related Premium Schedules and the Distribution of Risk   
  Using the predicted values from these two regression models shown in Table 1, we 
produce estimates of expected expense based upon an individual￿s age, gender, and health status.  
After incorporating administrative loading equal to 30 percent of the premium, this expected 
expense measure represents how risk-rated ￿spot market￿ insurance premiums (albeit rated by 
the set of risk characteristics identified in our empirical model) for our benchmark plan would 
appear.
7  Since our theoretical interest is in the schedule of renewable premiums for individuals 
who are all initially low risk, we exclude from the analysis individuals whose high-risk condition 
was discovered before the age of 18; the MEPS data indicate that only 2.5 percent of eighteen-
year-olds have one or more preexisting conditions.   
  Since the total number of high-risk individuals is (by definition) small, we increase the 
sample size for our subsequent analysis by using the full sample of non-elderly adults (regardless 
of their current insurance status) in the MEPS with non-missing data, producing a distribution of 
expected benefits as if the full non-elderly adult sample was insured by the benchmark plan.  
Since the number of high-risk observations is still somewhat limited for any given age, the 
estimates we present below use a weighted average of the surrounding ages to produce 
￿smoother￿ patterns.  Specifically, observations within seven years in age are used, but they are 
given a weight inversely proportional to the number of years￿ difference between the observation 
and the specific age being estimated.  The size of our resulting sample is 57,282 individuals.   
  Figure 2A and Figure 2B show the resulting estimated age profile of hypothetical low-
risk and high-risk premiums for females and males respectively.  The premiums for each age are 
shown in 2003 dollars.  Single-period risk-rated premiums would be less than $1000 for younger  10 
low-risk males and about $3000 for older low-risk males, but average about $2500 for younger 
high-risk males and about $7000 for older high-risk males.  It should be noted that these 
hypothetical ￿high-risk￿ premiums shown here are actually averages of the different rated 
premiums high-risk individuals would face based on the number and nature of their high-risk 
conditions.  The profile for average expense (from both low-risk and high-risk individuals 
together) by age is also shown.  The premium schedule represents how a ￿modified community 
rating￿ (i.e., permitting rating by age but not by health status) premium schedule would appear. 
  We then examine in more detail how the number of high-risk individuals increases.  The 
first row of Table 2 shows the proportion of the population who are high-risk by age; for 
simplicity, we present six selected ages at (roughly) ten-year intervals.  Approximately a quarter 
of both males and females (who are all initially low-risk at age eighteen) have developed a high-
risk condition by age 55, and almost 40 percent are high-risk by age 64.   
  Estimating the probability that a low-risk individual develops a high-risk condition 
during any given year that is implied by these estimates, however, needs to take account of 
deaths.  Since deaths occur more frequently to people with high-risk conditions, the per-period 
probability of becoming high-risk is larger than the value that would result from examining a 
static population without deaths.  To be specific, the annual probability of a low-risk individual 
becoming high-risk during age T can be expressed by the following:    
 P H,T = (NH,T+1 - (1- DH,T)NH,T) / (1- DL,T)NL,T),  
where Ni,T is the number of individuals of risk-type i at age T, and Di,T is the mortality rate of 
risk-type i at age T.   
We produce a ￿standardized￿ population by adjusting the ￿point-in-time￿ MEPS sample 
weights (which fluctuate, for example, with the presence of the ￿Baby Boom￿ population) using  11 
age/gender mortality rates from the National Center for Health Statistics [Anderson, 1999].  By 
age 64, a cohort of 100 low-risk males will have had about 21 deaths, so that there will be about 
47 low-risk members and 32 high-risk members remaining.  We use MEPS data for deaths that 
occurred within the sample to determine the ratio of low-risk to high-risk mortality, Di,T , for 
several selected age cohorts.  We apply this ratio to the NCHS age/gender mortality rates to 
determine age/gender/risk mortality rates needed to estimate the above expression for PH,T.   
The remainder of Table 2 shows the results from these calculations.  Conditional on age, 
mortality rates for high-risk individuals are almost ten times as high as mortality rates for low-
risk individuals.  The resulting annual likelihood of a low-risk individual developing a high-risk 
condition is less than 0.5 percent in the early stage of life but increases considerably to over 2.5 
percent in the later stage of life.  The estimates presented in this table have two direct 
implications for the gradient of the GR premium schedule.  The first is that many of those who 
develop a high-risk condition in their earlier years will die rather than continuing to incur high 
claims.  The second is that the pre-payment necessary to cover future claims for the younger 
cohorts is decreased by the relatively fewer individuals developing high-risk conditions during 
the earlier stages of life.   
 
II.C.  The Ideal Renewable Premium Schedule   
  Now consider the breakeven GR premium schedule implied by the theoretical work of 
Cochrane [1995] and Pauly, Kunreuther, and Hirth [1995].  These models specify that the 
premium at age T equals the low-risk expected expense at age T, plus the expected lifetime 
difference between low-risk and high-risk expected expense for all those individuals who 
become high-risk during age T.  That is, the GR premium in each period is front-loaded by an  12 
additional amount that essentially insures the financial consequences (until the person goes on 
Medicare at age 65) of becoming high-risk during the period.  For example, the premium at age 
64 is simply equivalent to the low-risk expected expense at age 64.  (All individuals who are 
high-risk before age 64 will have already covered their excess claims through prior front-loaded 
premiums.)  The premium at age 63 is the sum of the low-risk expense at age 63 plus the 
difference in expected expense between high-risk expected expense and low-risk expected 
expense at age 64 for the cohort of 63-year-old low-risks who become high-risk during age 63 
and are still alive at age 64.
8   
  As a result, low-risk individuals in any given year have no incentive to exit the pool of 
individuals covered by the GR policy for the risk-rated competitive ￿spot market￿ since the sum 
of their remaining expected lifetime GR premiums equals the sum of their remaining expected 
lifetime risk-rated premiums; an important assumption we make is that each consumer has the 
ability to predict what his or her feasible set of remaining premiums in this risk-rated spot market 
is, given his or her current health status, and makes a rational decision to either remain in or exit 
the GR pool.  High-risk individuals, of course, also have no incentive to leave the GR pool for 
risk-rated insurance since the GR premium schedule is much lower.  Moreover, even if some 
low-risk individuals did leave the GR pool for other reasons, their departure would not affect the 
insurer￿s ability to cover its future high-risk claims, since the funds for this purpose have already 
been prepaid by all insureds.   
  As discussed above, many individuals developing a high-risk condition may eventually 
recover from their illness￿generally within five years, if at all.  What matters for the incentive-
compatibility criteria to hold is only whether any individual gains by exiting the pool.  A 
formerly high-risk person who has recovered from a condition will have a lower expected  13 
expense than a person still suffering from that condition, but it is highly unlikely that the 
expected expense for individuals who have recovered from a condition is actually lower than the 
expected expense for low-risk individuals who have never had a high-risk chronic condition.
9  In 
other words, if the GR premium schedule is low enough so that a low-risk individual will not exit 
the pool to seek a risk-rated policy, it must be low enough for a formerly high-risk recovered 
individual not to exit either.   
  It is not a problem that we cannot obtain separate estimates of expected expense for 
recovered individuals and non-recovered individuals for those whose condition is more than five 
years old.  Determining the average of the two is sufficient because the excess premium that 
must be collected at age T is the sum of the lifetime difference in future expected expenses for all 
those developing a condition in T+1: those who recover, those who die after a time, and those 
who remain chronically ill.  This sum is the same whether it is comprised by the sum of the 
average excess expected expenses (of both recovered and non-recovered individuals) essentially 
estimated by our regression model, or by the sum of lower recovered individuals￿ average 
expense and higher non-recovered individuals￿ average expense.  However, there will be an 
overall effect of illness recovery on the steepness of the optimal GR premium schedule, since the 
average per-period expected expense for recovered and non-recovered individuals combined 
(i.e., the ￿more than five years￿ measures) is often lower than the expected per-period expected 
expense for newly-discovered conditions (i.e., the ￿one to five years￿ measures).  The future 
high-risk claims for the former are more concentrated in the younger cohort￿s premiums while 
the future high-risk claims for the latter are more concentrated in the older cohort￿s premium￿
simply because an older individual has less time to recover before the age of 64.    14 
  Finally, it is necessary to incorporate the overall growth in medical costs over time into 
our model.  GR policies typically stipulate that premiums can increase for all insured individuals 
within a rating class (the rating class we consider is the entire set of initially low-risk eighteen 
year olds).  Therefore it will be possible for the insurer to increase a ￿predetermined￿ schedule of 
premiums to reflect changes in medical prices and available technology.  However, since an 
incentive-compatible GR premium schedule must also be priced such that low-risk individuals 
wish to remain in the GR pool, the ￿class-average￿ increase in the GR premium can reflect only 
the currently low-risks￿ growth in expenses.  Therefore, it is necessary to apply a projected 
growth rate to the excess claims (i.e., the difference between high-risk and low-risk expense) 
incurred in periods T+1, T+2,￿, 64 for individuals who become high risk during period T to be 
set aside in reserve.   
  We use the projected growth rates for private health insurance from the National Health 
Expenditures data from the Centers for Medicare and Medicaid Services (CMS), given in Heffler 
et al. [2003].  Specifically, CMS projects premium growth equal to 7.7 percent per year for the 
period 2004-2008 and 6.9 percent per year for the period 2008-2012.  We assume that the 6.9 
percent growth rates prevails for the years beyond 2012, and we also assume that the growth rate 
is proportional to low-risk and high-risk costs alike.  Finally, we assume that insurers can earn a 
three percent real rate-of-return on these early-life ￿overcharges￿ set aside in reserve.  Hence, the 
excess cost-inflated prepayment we estimate is actually a discounted value.  That is, we assume 
that an insurer has to only collect $100 in excess premiums today, for example, to pay out $103 
in excess claims during the next year￿while this $103 in T+1 claims are essentially equivalent 
to $96 in claims in time T due to medical cost inflation.    15 
  Figure 3A and Figure 3B graph the incentive-compatible breakeven GR premium 
schedule we estimate, for females and males, respectively; Table 3 shows the magnitude of the 
premiums for several selected years.  The premiums for each age are shown in 2003 dollars.  
These figures illustrate that the GR premium schedule generally increases with age, despite the 
prepayment necessary to cover future high-risk claims; the main exception to this trend is the 
decrease in the GR premium for women after the peak child-bearing age.  The prepayment 
required (i.e., the difference between the future claims of newly high-risk individuals and low-
risk individuals) per year for the GR feature averages about $950 for both males and females, 
and is relatively level throughout one￿s lifetime until it begins to taper off during the fifteen years 
before age 65.  Over the course of one￿s lifetime, this prepayment required for the GR feature is 
about 50 percent above the low-risk premium which averages about $1800 for males and females 
of all ages; however, this ratio of the prepayment to the low-risk expense decreases considerably 
over time since the low-risk expected expense increases with age.  For males ages 18 to 34 the 
prepayment required is about $1050 per year which is about 175 percent above this young male 
cohort￿s low-risk premium averaging $600.  For females ages 18 to 34 the prepayment required 
is about $1200 per year which is about two-thirds of this cohort￿s low-risk premium averaging 
$1775.  
 
II.D.  Comparison to Actual Nongroup Premiums 
  We next compare our estimated GR premium schedules to actual data for nongroup 
insurance premiums.  The data sources for these premiums actually paid are the nationally-
representative 1996-1997 and 1998-1999 Community Tracking Study￿s (CTS) Household 
Surveys.  The sample we use consists of all of the persons with single-coverage nongroup plans  16 
(N = 1589) identified in these two surveys.  We make no adjustment for variation in generosity 
between these plans and our hypothetical benchmark plan, for whether a person is initiating or 
renewing coverage, for variation between the generosity of plans chosen and age-related 
expected expense, nor for state-level rating regulations.  However, we do adjust for growth in 
premiums both between 1996 and 2003 and between 1998 and 2003 using the CMS growth rates 
for private health insurance premiums, so that we present these CTS nongroup premium data in 
2003 dollars.   
  These mean nongroup premiums by age from the CTS data are shown in Figures 4A and 
4B for females and males, respectively; Table 3 shows the magnitude of these CTS premiums for 
several selected years.  While we have no objective measure of comparing the gradient of our 
hypothetical premium schedules with the premium schedule from actual nongroup purchases, 
there does appear to be surprising consistency between the age profile of actual nongroup 
premiums and the GR premium schedule we estimated.  Nongroup premiums do not increase 
proportionately with average age-related expense, and the magnitude of these premiums tapers 
off considerably during the ten years before Medicare eligibility.
10  However, since the CTS 
premium schedule also happens to be similar in shape to the low-risk premium schedule (because 
the expected expenses for those who remain low-risk also increases less rapidly with age than do 
average expected expenses), an alternative hypothesis would be the existence of strict 
underwriting to exclude all high-risk individuals from nongroup insurance.  The publicly-
available version of the CTS survey does not contain information on specific chronic health 
conditions but does contain self-reported health status: 7.8 percent of individuals between age 18 
and 64 with employment-based health insurance report their health as fair or poor, while 7.0 
percent of the nongroup insured sample report their health as fair or poor.  Such strict  17 
underwriting to exclude all high risks from our nongroup sample, therefore, is not likely.  While 
the existence of underwriting may have some effect on the pattern on nongroup premiums we 
observe, we conclude that the pattern of actual premiums is consistent with the hypothesis that 
insurers are actually charging lifetime GR premiums.   
 
II.E.  GR Premium Schedules Under Alternative Assumptions   
  One important influence on the magnitude of the prepayment necessary to fund the GR 
feature is the assumption made about the rate-of-return that insurers can earn on the early-life 
overcharges set aside in reserve.  We assumed a modest three percent rate-of-return for the 
breakeven GR premium schedule shown above, but higher expected rates-of-return would 
obviously result in a lower amount of front-loading necessary.  For purposes of illustration, we 
estimate breakeven GR premium schedules resulting from assuming that the rate-of-return 
insurers earn on reserves simply equaled the expected growth in medical expenditures; these 
schedules are shown in Figures 5A and 5B for females and males, respectively, and Table 3 
shows the premiums for selected years.  This alternative assumption about the rate-of-return 
lowers the average prepayment across all ages from about $950 to about $525 per year and 
decreases this amount by a relatively higher amount for younger individuals.   
  A second important influence on the degree of necessary front-loading is enrollee 
turnover.  In real insurance markets relatively few people buy an individual insurance policy at a 
young age and stick with it until they go on Medicare.  The turnover in the individual market is 
relatively high, especially because people move back and forth between the individual and (tax-
subsidized) group markets.  Such turnover makes GR less valuable to consumers on average, but  18 
it would also make the policy cheaper since insurers would not have to collect as much money to 
set aside in reserve for high-risk individuals.   
  To illustrate this point, we assume that a small fraction of individuals will leave the plan 
each year due to exogenous shocks but that the likelihood of leaving, given such a shock, is 
lower for those who have become high-risk.  Specifically, we first assume that the median length 
of stay in the plan is five years for low-risk individuals and twenty years for high-risk 
individuals; that is, we assume a per-period probability of leaving the plan equal to 
approximately 3.402 percent for high-risk individuals.  The resulting GR premium schedule for 
this ￿low turnover￿ scenario is shown in Figures 5A and 5B and in Table 3; this set of 
assumptions lowers the average prepayment of the GR feature above the low-risk expected 
expense from about $950 to about $600 with (as expected) a larger effect on decreasing the 
degree of front-loading for younger individuals.   
  We also consider a ￿high turnover￿ scenario in which we assume the median stay for 
high-risk individuals is only ten years by assuming their per-period probability of leaving the 
plan equals 6.693 percent.  This increased turnover would result in GR premiums schedule with 
the average prepayment necessary to cover future claims lowered to about $400.  A fuller 
analysis incorporating consumer turnover is not possible here, but the main implication we want 
to note is that, in practical terms, the ￿horizon￿ that insurers typically take into account in 
thinking about and pricing GR is usually five to at most ten years, and so these illustrative 
breakeven GR premium schedules which incorporate turnover may be closer to reality than the 
hypothetical ones presented earlier.   
  19 
III.  OTHER ISSUES 
III.A.  Consumer Willingness-to-Pay for GR   
  Up to this point, we have examined breakeven GR schedules that cover lifetime insurer 
costs and only ensured that low-risk consumers are indifferent between the future costs of the 
GR schedule and their expected future costs of alternative risk-rated schedules.  On the one hand, 
risk-averse insureds would in principle be willing to pay more than the cost for something that 
protected them from uncertainty.  On the other hand, Frick [1998] has argued that capital market 
imperfections may limit a younger individual￿s ability to afford the excess front-loading that 
must be collected.  Thus, consumers might react by choosing policies without GR.  Is this likely 
to happen?  One way to answer this question is to estimate the valuation of the reduction in 
uncertainty associated with the GR feature and compare it with an estimate of the ￿costs￿ of 
assumed capital market constraints.  The sum of these two components is then the net utility gain 
or loss from GR.     
  The benefit to consumers is the reduction in the uncertainty associated with random 
future-period premiums that one would face in a risk-rated spot market in the absence of GR 
insurance.  The value of this benefit can be estimated as ‰ AP var(P), where AP is the Arrow-
Pratt absolute risk-aversion coefficient and var(P) is the variance of the alternative set of risk-
rated premiums one faces.  (See, for example, Feldman and Dowd [1991] for a derivation of this 
expression.)  Marquis and Holmer [1986] produced estimates of the Arrow-Pratt absolute risk-
aversion coefficient of 0.0011 and 0.00084 in 1982 dollars.  Taking the average of these two 
estimates and multiplying it by the ratio of the 1982 CPI (100.00) to the 2003 CPI (188.29) taken 
from the Bureau of Labor Statistics [2003] gives an estimate of the Arrow-Pratt absolute risk-
aversion coefficient equal to 0.00052 in 2003 dollars.    20 
  The relevant uncertainty a low-risk individual faces at age T is the variation in future-
period wealth related to becoming high risk during age T.  (The variation in future premiums for 
a low-risk individual opting out of the GR pool before age T that would result from becoming 
high risk during age T + 1 or later is not included in the measure for age T, so as to not ￿double 
count￿ the gain in utility from the GR feature.)  Specifically, for age T, we identify the 
distribution of risk-rated premiums an individual who is low-risk at age T faces in each 
remaining year (i.e., T +1, T + 2,￿, 64) if that individual either stayed low-risk or became high-
risk during age T.  As before, the set of future premiums are inflated according to the CMS 
projections in private health insurance premiums.  We then estimate the variance for each of 
these 64 - T years faced at age T , use each computed variance to estimate that year￿s Arrow-
Pratt valuation of uncertainty, and calculate the total discounted sum to give the value for age T.  
(The consumer discount rate we use is discussed below.)   
  Now consider the ￿capital constraint￿ cost resulting from the prepayment of future-period 
excess claims from high-risk individuals.  That is, there is an opportunity cost to the consumer of 
foregone consumption associated with the prepayment of the GR feature; however, this 
opportunity cost is offset by the return-on-investment that insurers earn on their reserves.   We 
generate two sets of results by assuming that the magnitude of the consumers￿ discount rate 
equals five percent and ten percent.
11  These consumer discount rates are applicable not only to 
the capital constraint cost, but also to individuals￿ valuation of each future-period￿s reduction in 
uncertainty; the more myopic individuals are, they will place less emphasis on reductions in the 
variation in wealth which occur farther in the future.   
  Figures 6A and 6B show estimates for the willingness-to-pay for the GR feature, for 
females and males respectively, assuming a consumer discount rate of five percent; the top panel  21 
of Table 4 presents mean values for these estimates by age range.  With a relatively low discount 
rate, the per-period valuation of the reduction in uncertainty averages about $2100 for females 
and about $2200 for males; for both females and males, the valuation of the reduction in 
uncertainty is slightly larger for the middle-aged cohort relative to the younger cohort, but it 
decreases considerably for the older cohort.  Although younger individuals face a potentially 
longer lifetime of high premiums if they develop a chronic condition while young, the relatively 
level pattern for the valuation in risk with age seems to be driven primarily by the higher per-
period probability of becoming high-risk condition as age increases.  The capital constraint cost 
associated with the prepayment of premiums averages about $250 for both females and males.  
This capital constraint cost decreases with age similarly for both females and males.  As a result, 
the net utility gain of the breakeven GR schedule averages about $1850 for females and $1950 
for males.  For both females and males, the net utility gain is always positive and relatively level 
across all ages, although it is highest for the middle-aged cohort.  Thus, for all individuals, even 
with a relatively low discount rate of five percent, the value of the GR feature is quite high.   
  Figures 7A and 7B and the bottom panel of Table 4 show the estimates of the utility gain 
from the breakeven GR premium schedule if the discount rate is assumed to be a higher value 
equal to ten percent.  The higher discount rate both decreases the valuation of the reduction in 
uncertainty (from about $2150 to about $1200) and increases the magnitude of the capital 
constraint cost (from about $250 to about $550), thereby decreasing the net utility gain from the 
GR feature to between $650 and $675.  The higher discount rate has the largest impact on the 
younger cohort; this is driven primarily by the significant decrease in the valuation of uncertainty 
resulting from having relatively less concern with fluctuations in future-period risk-rated 
premiums in the spot market.  The net utility gain from the GR feature becomes negligible for  22 
younger females, while it actually becomes negative for younger males, averaging about -$150, 
although the net utility remains positive for older individuals.  Therefore, under this set of 
assumptions, males under the age of 30 would not be willing to purchase this breakeven GR 
policy, since the capital constraint cost exceeds the valuation of the reduction in uncertainty.   
  These calculations for consumers￿ willingness to pay for the GR feature imply that 
consumers would be willing to pay a premium at each age equal to the sum of the breakeven GR 
premium and the net utility gain from the GR feature.  However, this does not imply that there is 
actually a range of feasible GR premium schedules that could exist.  Bertrand price competition 
by insurers implies that the breakeven GR premium schedule we have estimated is the unique 
equilibrium that will exist in the market.  An insurer could not offer an alternative premium 
schedule with lower younger-age premiums subsidized by higher older-age premiums, since the 
low-risk older insureds will be attracted to other insurers offering the breakeven GR premium 
schedule.   However, the possibility that the net utility gain of the GR feature for younger 
individuals is not positive (e.g., males under the age of 30 assuming a 10 percent discount rate) 
does not imply that GR policies will cease to exist for all consumers.  Rather, GR policies 
(whose premiums schedule will be equivalent to the breakeven GR schedule we have estimated) 
would exist for the cohort of low-risk consumers for whom both the current and future utility 
gains are nonzero (e.g., low-risk 30 year-old males).   
 
III.B.  Lifetime Non-Medical Consumption Smoothing   
  An alternative way of examining the possible role of capital constraints builds on Frick￿s 
[1998] insight that individuals should generally seek to smooth lifetime consumption, but the 
typical pattern of lifetime savings combined with capital constraints limits their ability to do so.   23 
If we think of the relevant consumption as total spending minus medical insurance premiums, the 
pattern of premiums (which are lower when younger) is offset by the typical earnings pattern 
(which is also lower when young).  But would the average age-related expense or the GR 
premium schedule produce a smoother pattern of non-medical consumption?   
  To address this question, we obtain data for total annual income from the March 2002 
Current Population Survey (CPS) for fulltime workers, and inflate these amounts to 2003 
dollars.
12  Table 5 describes the feasible consumption patterns assuming neither borrowing nor 
lending for a typical production worker.  Specifically, we show the non-medical consumption 
(i.e., total income minus the premium) as a percentage of total income for both the age-rated 
premium schedule and the breakeven GR premium schedule.  For both males and females, the 
non-medical consumption resulting from an age-rated premium schedule is relatively level 
during the younger ages but then decreases considerably during the ten-to-fifteen years before 
Medicare eligibility.  Alternatively, the non-medical consumption resulting from the breakeven 
GR premium schedule is lowest when workers are young (coinciding when these youngest 
workers earn much lower incomes) and then relatively level during the middle and older ages.   
  However, since the breakeven GR premium schedule under consideration includes 
prepayments for future medical claims incorporating medical cost growth rates, it is not entirely 
appropriate to compare this GR premium schedule (deflated to 2003 dollars) that an individual 
faces to current levels of income (as opposed to growing incomes, albeit growing less rapidly 
than medical services costs) and age-rated premiums for other cohorts.  Therefore, in the bottom 
panel of Table 5, we present expected lifetime income and premium amounts for a cohort of 
eighteen-year-old individuals looking towards the future.  For these estimates, we assume annual 
three percent growth in income (relative to older cohorts￿ current levels of income) and use the  24 
CMS growth rates for private health insurance premiums described above.  Although the GR 
premiums schedules generate relatively lower levels of non-medical consumption at the youngest 
age, the GR premium schedule produces a much more smooth level of future non-medical 
consumption than does the age-rated premium schedule.   
 
III.C.  Underwriting and GR   
  We have assumed to this point that the population of potential insurance purchasers 
consists of low risks.  This is approximately true at young ages.  Less than ten percent of people 
in their twenties have a pre-existing medical condition.  If the process of underwriting is costly to 
insurers, it may even be the case that the costs of screening younger applicants for many high-
risk conditions would outweigh the consequences resulting from adverse selection, and hence it 
is conceivable that almost all young applicants would be enrolled.  If the purchase of insurance is 
contemplated at an older age, however, we would expect to see underwriting to screen out high-
risk applicants.  Since the optimal GR premium schedule is defined by the incentive-
compatibility of low-risk individuals at each age, older low-risk applicants could join an existing 
GR pool and pay the same future premium schedule.  High-risk applicants who are underwritten 
would face higher premiums but could still perhaps take advantage of an alternative GR feature.  
Since risk level is actually a continuum, it is conceivable that a population of middle-age 
applicants who are moderate risk (e.g., one pre-existing conditions) could form their own GR 
pool to insure against the uncertainty of becoming even higher risk (e.g., two or more pre-
existing conditions).   
  25 
III.D.  Forecasting Future Growth in Spending   
  As noted earlier, a potential problem with GR contracting is the magnitude and 
uncertainty of future medical spending.  This risk is alleviated somewhat by the ￿renewal at 
class-average rates￿ feature, but since the incentive-compatible GR feature involves prepayment 
of future claims for high-risk individuals, some potentially non-diversifiable risk to the insurer 
will remain.  This remaining risk is essentially the spread between forecasted and realized cost 
growth times the proportion of the claims subject to this risk, which we estimate to be about 35 
percent￿based upon an average GR prepayment of $950 (which is subject to this uncertainty) 
and an average low-risk expense of $1800 (which is not subject to this uncertainty).   
  High unanticipated medical cost growth (thereby resulting in a plan having undercharged 
and under-reserved) could explain the practice of terminating rating classes without attributing 
such observed behavior to an ￿underhanded￿ motive.  That is, suppose that an insurer had 
incorrectly underestimated future cost growth where the higher growth actually occurred, and it 
adjusted the subsequent period￿s premium upward￿for both low-risk and high-risk 
individuals￿to simply cover the increase in costs resulting from excess claims from high-risk 
individuals.  For how long would the adjusted premium still appeal to low-risk individuals (since 
they have a net utility gain from the GR feature) before (potentially) increasing too much?  To 
address this question, we consider an insurer￿s na￿ve GR premium schedule resulting from its 
simply assuming three percent growth in medical expenditures offset by its three percent rate of 
return on its reserves.  We then assume that the insurer adjusts the initial na￿ve GR premium 
schedule upwards in each subsequent year to pay for the unanticipated cost growth (assumed to 
ex post be seven percent).  We observe how soon low-risk individuals would discontinue  26 
purchasing this adjusted GR plan￿based upon when (or if, for that matter) the plan￿s necessary 
upward adjustment exceeds the individual￿s willingness-to-pay for the GR feature.   
  We first consider the willingness-to-pay associated with a five percent consumer discount 
rate; recall that this assumption generated a positive utility gain averaging about $1900.  For an 
initial cohort of eighteen year olds, an upwards-adjusted premium schedule to cover such 
unanticipated cost growth would actually remain incentive-compatible until age 43 for females 
and age 45 for males; after twenty-five years, low-risk individuals would no longer be willing to 
remain in this pool.  We then consider the willingness-to-pay associated with a ten percent 
discount rate; this assumption generated an average utility gain of just over $650, but was 
generally negative for males and females in their twenties.  Here we consider an initial cohort of 
thirty-five year olds (for whom the optimal breakeven GR premium schedule would be 
incentive-compatible).  For this cohort, upwardly adjusting a na￿ve GR premium schedule would 
instead remain incentive compatible for only twelve years￿specifically, until age 47 for females 
and 48 for males.  After twelve years, individuals who remained low risk would no longer be 
willing to purchase the policy and this na￿ve insurer would have to cancel the rating class to 
avoid losing money.   
  However, as a modest proposal, we suggest that there may be a potential way in which an 
insurer could diversify this remaining risk related to ￿unforeseen￿ cost growth.  It is likely that 
the profits of health care companies (e.g., for-profit hospital chains, pharmaceutical companies) 
are positively correlated with the rate of growth in medical spending.  If this were the case, an 
insurer that invested its GR reserves into a portfolio of stocks of such companies should receive 
returns that are negatively correlated (and hence diversified) with the fluctuations in its own GR 
reserves set aside for future high-risk claims.    27 
 
IV.  CONCLUSION 
  This paper therefore draws optimistic implications for GR in individual health insurance.  
The feature is virtually universal even without regulation in term life insurance, so health 
insurers should be and probably are familiar with the need for some frontloading of premiums.  
But what is less clear is whether they are aware of the desires of the low risks who need to be 
kept in the pool.  Despite the moderately low cost of the GR feature, younger individuals who 
place a high value on current levels of consumption may still not be willing to pay this low cost 
unless the breakeven GR premium is subsidized.  Regardless, it does seem that existing 
breakeven schedules come reasonably close to optimal incentive-compatible patterns.    28 
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Notes:  
                                                 
1  Even before the Health Insurance Portability and Accountability Act (HIPAA) of 1996 requiring guaranteed renewability of all 
nongroup insurers, many states had their own GR regulations in effect [Pauly, Percy, and Herring, 1999].  Although the HIPAA 
law is somewhat incomplete in that it does not require premiums to be the same for all individuals within a rating class, Patel and 
Pauly [2002] find, in a national survey of insurance regulators, that 47 states do have this requirement.   
 
2  Cutler [1993] has argued that such inter-temporal uncertainty in the costs of long-term care has resulted in a failure to 
completely insure nursing home care.   
 
3  The practice of ￿re-underwriting￿ by a health insurer in Florida was highlighted a year ago in the Wall Street Journal [Terhune, 
2002].  Although this article received a fair amount of attention, this practice is generally considered to be an anomaly within the 
industry.   
 
4  In principle, it would be possible to determine the premiums presented below by simply computing the average actual expense 
for the relevant sub-sample.  However, we are primarily interested in producing estimates for high-risk individuals both as a 
function of their current age and the age at which their high-risk condition was first discovered.  Since the reliability of such 
estimates from so many different small-size samples of high-risk individuals would be quite low, we use the following regression 
model instead.   
 
5  We use a traditional two-part methodology for estimating expected expenses to handle the clustering of those with zero actual 
expense [Duan et al., 1983], but we decide not to use a transformed dependent variable in the second stage model estimating 
nonzero expenses.  We have found that using untransformed linear expenses increases the model￿s ability to more accurately 
estimate the right tail of the expense distribution than using either logarithmic or square-root ￿smearing￿ models [Pauly and 
Herring, 1999; Herring and Pauly, 2001].   
 
6  The year that an existing condition was discovered is missing for a fraction of the observations in the MEPS.  (There is, 
however, complete data for whether an individual has ever been made aware by a physician about the condition.)  Rather than 
delete these observations and re-weight those observations with non-missing data, we wish to retain as many high-risk 
observations in the data as possible; we therefore impute the date discovered for those with missing data using the age 
distribution of conditions discovered during the MEPS sample year.   
 
7  We should note that neither the assumptions about the AAA induction methodology, the inflator parameter to generate 
expenses in 2003 dollars, nor the magnitude of the administrative loading affects the patterns of the resulting premium gradients 
by age.  Instead these assumptions are made simply to generate overall magnitudes that appear realistic.   
 
8  To be clear, the premium at age 62 is the sum of the low-risk expense for 62-year-olds plus the difference in lifetime expected 
expense between high-risk expected expense and low-risk expected expense (for both 63-year-olds and 64-year-olds who remain 
alive) for the proportion of 62-year-old low-risks who develop a condition during age 62.   
 
9  We cannot verify this empirically with the MEPS, however, because it is not feasible to accurately distinguish ex ante a 
formerly high-risk recovered individual from a currently high-risk non-recovered individual with a two-year panel.   
 
10  One comparison can be made by regressing the average actual nongroup premium from the CTS on the age-related average 
expense and regressing the nongroup premium on the hypothetical GR premium schedule.   Using logs for these measures to 
generate an elasticity estimate, the elasticity of actual premiums with respect to age-related average expense (in results not 
shown) was 0.45 for males and 0.57 for females, while the elasticity of the CTS premiums with respect to the GR premium 
schedule was 1.11 for males and 1.11 for females.  This informal comparison implies that the slope of the GR premium schedule 
is considerably closer to the slope of the actual nongroup premium schedule than to the slope of age-related average expense.   
 
11  If individuals have the same discount rate as insurers (i.e., three percent), the opportunity cost of the early-life ￿overcharges￿ 
will simply offset the return-on-investment that insurers earn on this money set in reserve.  The net utility gain of the GR feature 
then would solely equal the benefit from the reduction in uncertainty.   
 
12  We thank Peter Joski for providing these estimates for income from the CPS.    30 
Table 1 














b   1970.1           
Total benefits
b 1571.8          
Any positive benefits
b  0.558  -0.917  ***       
Total nonzero benefits
b   2816.1      1486.7  ***   
Male ages 18 to 24  0.0554 -0.004     24.3     7.0
Male ages 25 to 29  0.0461 -0.121     -228.2     -114.8
Male ages 30 to 34  0.0585        
Male ages 35 to 39  0.0700 0.215  ***  103.3     116.0
Male ages 40 to 44  0.0735 0.262  ***  506.7     296.5
Male ages 45 to 49  0.0634 0.553  ***  777.8  *  563.5
Male ages 50 to 54  0.0547 0.816  ***  1169.5  ***  916.4
Male ages 55 to 59  0.0385 0.894  ***  2263.7  ***  1565.2
Male ages 60 to 64  0.0303 1.344  ***  2575.3  ***  2158.9
Female ages 18 to 24  0.0554 0.889  ***  193.6     430.6
Female ages 25 to 29  0.0496 1.455  ***  833.3  *  1086.6
Female ages 30 to 34  0.0612 1.349  ***  1132.6  ***  1226.5
Female ages 35 to 39  0.0707 1.200  ***  1175.9  ***  1164.0
Female ages 40 to 44  0.0762 1.310  ***  943.6  **  1081.9
Female ages 45 to 49  0.0671 1.443  ***  679.8  *  977.6
Female ages 50 to 54  0.0579 1.781  ***  1013.0  **  1375.3
Female ages 55 to 59  0.0402 1.892  ***  1813.6  ***  2033.9
Female ages 60 to 64  0.0313  2.048  ***  2299.4  *** 
2505.4 
Cancer, one to five years ago 0.0039 1.658  ***  12108.0  ***  10848.4
Cancer, more than five years ago 0.0055 1.810  ***  6060.5  ***  5910.9
Diabetes, one to five years ago 0.0061 2.014  ***  1653.5  ***  2215.0
Diabetes, more than five years ago 0.0104 1.927  ***  697.0     1347.7
Emphysema, one to five years ago 0.0007 0.751     4800.3  **  3718.9
Emphysema, more than five years ago 0.0006 11.482     -1653.0     -653.2
High cholesterol, one to five years ago 0.0070 1.697  ***  61.6     737.6
High cholesterol, more than five years ago 0.0120 1.748  ***  -312.6     432.6
Hypertension, one to five years ago 0.0171 1.858  ***  763.9  **  1400.8
Hypertension, more than five years ago 0.0364 1.664  ***  -285.2     453.3
Heart disease, one to five years ago 0.0047 2.255  ***  5687.6  ***  5935.9
Heart disease, more than five years ago 0.0110 2.207  ***  4166.6  ***  4537.7
Stroke, one to five years ago 0.0005 1.325     2911.1     2888.4
Stroke, more than five years ago 0.0006 11.571     9860.3  ***  10860.4
Arthritis, one to five years ago 0.0077 0.970  ***  1584.9  ***  1615.5
Arthritis, more than five years ago 0.0153 1.083  ***  842.2  **  1125.9
Asthma, one to five years ago 0.0018 0.962  ***  6029.9  ***  4880.9
Asthma, more than five years ago 0.0152 1.246  ***  1171.0  ***  1460.6
Gall bladder disease, one to five years ago 0.0006 2.812  ***  3475.2  *  4147.8
Gall bladder disease, more than five years ago 0.0007 1.576  **  6532.7  ***  6074.7
Stomach ulcer, one to five years ago 0.0007 0.537     1126.8     1004.3
Stomach ulcer, more than five years ago 0.0017 1.485  ***  987.1     1428.0
Back problems, one to five years ago   0.0139 0.704  ***  509.2     685.6
Back problems, more than five years ago 0.0331 0.791  ***  660.6  **  837.4
Number of observations  33,884 33,884 18,652  
-2 Log Likelihood    -40944     
Adjusted R-squared  0.0412   
 
Source:  1996, 1997, 1998, and 1999 Medical Expenditure Panel Surveys.   
p-values:  Statistical significance at 0.01 or better (***); between 0.01 and 0.05 (**); between 0.05 and 0.10 (*) 
a Sample includes all privately-insured adults between 18 and 64, excluding those with public insurance.     
b Total expenditures are in 2003 dollars and are standardized to a benchmark plan; see text for details.   
c Model predicts the likelihood of having any positive insurance benefits.   
d Model predicts the magnitude of total benefits, conditional on having non-zero benefits.    31 
Table 2 




  18 25 35 45 55 63 64 
F e m a l e s :          
  Proportion that are high-risk  0.0  3.9 8.5 16.6 27.5 38.4 39.4 
  Number that are alive
a  100.0 99.7 98.9 97.5 94.3 88.7 87.7 
  Number that are low-risk
a  100.0 95.7 90.5 81.3 68.3 54.7 53.1 
  Number that are high-risk  0.0  3.9 8.4 16.2 25.9 34.1 34.6 
  Probability of dying, low-risk
b  0.05 0.04 0.06 0.09 0.16 0.27 n/a 
  Probability of dying, high-risk
b 0.44 0.38 0.57 0.83 1.48 2.49 n/a 
  Probability of becoming high-risk
b  0.80 0.51 0.85 1.67 3.17 2.56 n/a 
         
Males:         
 Proportion that are high-risk  0.0  3.0 7.9 15.3 26.9 38.4 39.3 
  Number that are alive
a  100.0 99.0 97.2 94.3 88.9 80.3 78.8 
  Number that are low-risk
a  100.0 96.0 89.5 79.9 65.0 49.4 47.8 
  Number that are high-risk
a  0.0  3.0 7.7 14.5 23.9 30.8 30.9 
  Probability of dying, low-risk
b  0.13 0.12 0.14 0.18 0.28 0.46 n/a 
  Probability of dying, high-risk
b   1.16 1.12 1.28 1.67 2.55 4.18 n/a 
  Probability of becoming high-risk
b  0.41 0.54 0.78 1.64 1.93 2.80  n/a 
 
Sources:  1996, 1997, 1998, and 1999 Medical Expenditure Panel Surveys.  National Center for Health Statistics 
[Anderson, 1999].   
a The MEPS sample weights are normalized to examine an initial population of 100 eighteen-year old females and 
100 eighteen-year-old males.  More details about the sample weight modification is presented in the text.   
b The probabilities of dying and the probability of becoming high-risk are all annual rates; e.g., the probability of 
becoming high risk at age 25 is the likelihood of a low-risk 25-year old individual developing a high-risk 
condition before age 26.    32 
Table 3 




  18 25 35 45 55 64 
F e m a l e s :         
  Low-risk premium 1208 1772 2187 2051 2985 4009 
  High-risk premium  n/a 5070 5168 5039 6680 8027 
  Age-rated premium 1208 1902 2440 2548 4002 5594 
  GR premium  2291 2955 3556 3043 3534 4009 
  CTS nongroup premium  1638 1776 2135 2584 3205 3687 
  GR premium with higher return 1605 2278 2923 2718 3444 4009 
  GR premium with low turnover  1709 2390 3039 2783 3463 4009 
  GR premium with high turnover 1454 2100 2718 2589 3402 4009 
       
Males:       
  Low-risk premium 611 540 711 1190 2254  3402 
  High-risk premium  n/a 1929 2838 4172 6603 8819 
  Age-rated premium 611 582 879 1648 3424  5530 
  GR premium  1536 1436 2048 2294 3005 3402 
  CTS nongroup premium  1539 1712 1893 2727 3663 4143 
  GR premium with higher return 892  894 1365 1932 2875 3402 
  GR premium with low turnover  986  983 1488 2005 2902 3402 
  GR premium with high turnover  762  756  1152  1788  2815  3402 
 
Sources:  1996, 1997, 1998, and 1999 Medical Expenditure Panel Surveys; 1996-1997 and 1998-1999 
Community Tracking Study Household Surveys.   
a  Each premium is given in 2003 dollars.    33 
Table 4 
Average Net Utility Estimates by Age Range 
 
 Age  Range: 
  18-34 35-49 50-64 Entire 
Five percent discount rate:           
   Females:     
     Benefit: uncertainty reduction 2274  2537 1424 2099 
     Cost: capital constraint -414  -247 -38 -245 
     Net utility 1860 2289 1385 1853 
    
   Males:     
     Benefit: uncertainty reduction 2037  2596 1947 2192 
     Cost: capital constraint -405  -258 -54 -254 
     Net utility 1632 2338 1893 1938 
    
Ten percent discount rate:           
   Females:     
     Benefit: uncertainty reduction 908  1510 1230 1201 
     Cost: capital constraint -847  -602 -112 -543 
     Net utility 62 908 1118 658 
    
   Males:     
     Benefit: uncertainty reduction 657  1527 1651 1232 
     Cost: capital constraint -813  -625 -158 -559 
     Net utility  -157  902  1493  673 
 
  Note:  The methodology for these estimates is provided in the text; values are given in 2003 dollars.    34 
Table 5 




  18 25 35 45 55 64 
Females:        
  Total income (I)
a    13,686 27,443 37,525 40,112 41,478 36,531 
  Age-rated premium 1,208 1,902 2,440 2,548 4,002 5,594 
  GR premium 2,291 2,955 3,556 3,043 3,534 4,009 
  C/I:
b  average premium 0.91 0.93 0.93 0.94 0.90 0.85 
  C/I:
b  GR premium 0.83 0.89 0.91 0.92 0.91 0.89 
   
Males:   
  Total income (I)
a    14,265 31,408 52,040 62,291 66,636 66,399 
  Age-rated premium 611 582 879 1,648 3,424 5,530 
  GR premium 1,536 1,436 2,048 2,294 3,005 3,402 
  C/I:
b  average premium 0.96 0.98 0.98 0.97 0.95 0.92 
  C/I:
b  GR premium 0.89 0.95 0.96 0.96 0.95 0.95 
    
 Year: 
  2003 2010 2020 2030 2040 2049 
Females, currently age 18:        
  Future total income (If)
c    13,686 33,752 62,024 89,101 123,822 142,288 
  Future age-rated premium
d 1,208 3,149 7,874 16,028 49,045 124,996 
  Future GR premium
 d 2,291 4,893 11,477 19,136 43,317 89,588 
  C/If:
b  future age-rated premium 0.91 0.91 0.87 0.82 0.60 0.12 
  C/If:
b  future GR premium 0.83 0.86 0.81 0.79 0.65 0.37 
    
Males, currently age 18:    
  Future total income (If)
c    14,265 38,628 86,015 138,367 198,924 258,629 
  Future age-rated premium
d 611 964 2,837 10,361 41,964 123,557 
  Future GR premium
 d 1,536 2,378 6,608 14,426 36,832 76,025 
  C/If:
b  future age-rated premium 0.96 0.98 0.97 0.93 0.79 0.52 
  C/If:
b    future  GR  premium  0.89 0.94 0.92 0.90 0.81 0.71 
 
Sources:  1996, 1997, 1998, and 1999 Medical Expenditure Panel Surveys; 2002 Current Population Survey.   
a  Total income (I) is for fulltime workers and is presented in 2003 dollars.   
b  Consumption (C) is defined as total income minus the relevant health insurance premium.   
c  Future total income (If) is for fulltime workers and is presented for the relevant future year, assuming 
annual three percent growth above current ages￿ levels.   
d  Future premiums assume projected growth rates presented in Heffler et al. [2003].  The annual growth rate 
for years 2004-2008 is projected to be 7.7 percent, the annual growth rate for years 2009-2012 is 
projected to be 6.9 percent, and we assume a 6.9 annual growth rate for years 2013 and beyond.   
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Figure 1 
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Note:  The GR premium schedule shown here assumes that individuals are either low-risk 
or high-risk and that there is a constant per-period probability of low-risk individuals 
becoming (and staying) high-risk.  By the final period of the model, one-half of the 
population is high-risk.   
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Figure 2A 






























































  Note:  These estimates are given in 2003 dollars.    37 
Figure 3A 
































































  Note:  These estimates are given in 2003 dollars.    38 
Figure 4A 


































































  Note:  These values are given in 2003 dollars.    39 
Figure 5A 
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  Note:  These estimates are given in 2003 dollars.    40 
Figure 6A 




















































































  Note:  The methodology for these estimates is provided in the text; values are given in 2003 dollars.    41 
Figure 7A 




















































































  Note:  The methodology for these estimates is provided in the text; values are given in 2003 dollars.   
 